Dermapharm Holding SE buy Maxi_Scalibusa
Start price
23.04.19
/
50%
€31.50
Target price
04.11.21
€60.00
Performance (%)
184.60%
End price
05.11.21
€89.65
Summary
This prediction ended on 05.11.21 with a price of €89.65. The BUY prediction by Maxi_Scalibusa for Dermapharm Holding SE saw massive gains of 184.60%. Dividends of €1.57 are taken into consideration when calculating the performance. Maxi_Scalibusa has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 0.437% | 0.437% | 21.854% | 0.349% |
| iShares Core DAX® | -0,20 % | 5,47 % | 9,19 % | 48,66 % |
| iShares Nasdaq 100 | 2,57 % | 10,09 % | 39,29 % | 95,72 % |
| iShares Nikkei 225® | 0,60 % | 9,87 % | 46,20 % | 63,77 % |
| iShares S&P 500 | 1,80 % | 7,40 % | 29,62 % | 67,24 % |
Comments by Maxi_Scalibusa for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten